Researchers from Wuhan University and Columbia University find that SA55, a monoclonal antibody, strongly neutralizes SARS-CoV-2, including JN.1 subvariants.

Unlike pemivibart, SA55 resists viral escape, likely due to its stronger binding.

https://www.biorxiv.org/content/10.1101/2025.02.12.638008v1

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service